Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. On December 6, 2024, Yield10 Bioscience, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on October 14, 2025.
Frequently asked questions
What sector does Yield10 Bioscience, Inc. (YTENQ) operate in?
Yield10 Bioscience, Inc. belongs to the Healthcare sector and operates in the Agricultural Inputs industry.
What is Yield10 Bioscience, Inc. (YTENQ) current stock price?
As of the latest data, Yield10 Bioscience, Inc. stock price is $0.00, with a previous close of $0.00.
What is Yield10 Bioscience, Inc. (YTENQ) current market capitalization?
Yield10 Bioscience, Inc. market cap is approximately 69.27.
What is Yield10 Bioscience, Inc. (YTENQ) Earnings Per Share (EPS)?
The trailing EPS is -$22.56.
Does Yield10 Bioscience, Inc. (YTENQ) pay dividends?
No. Yield10 Bioscience, Inc. does not pay a dividend.
What is Yield10 Bioscience, Inc. (YTENQ) beta (volatility) score?
Yield10 Bioscience, Inc. has a beta of 31.170, indicating very high volatility compared to the market.
